Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Re-Endothelialization Might Not be the Unique Solution to Prevent Restenosis. The EREMUS Study

NCT00870038 is registered in ClinicalTrials.gov with Ospedale della Misericordia as lead sponsor.

NCT NCT00870038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Re-Endothelialization Might Not be the Unique Solution to Prevent Restenosis. The EREMUS Study
Lead sponsor
Ospedale della Misericordia
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2010
Completion date
January 31, 2012
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary, percutaneous coronary intervention